Moderna Stock Sinks. It Disappoints With Covid-19 Vaccine Forecast.
Moderna laid out sales expectations for the coming year on Monday that were below even the much-diminished Wall Street expectations. The stock was falling 14% to $35.71 in premarket trading. The biotech that became a household name during the Covid-19 pandemic in 2020 has struggled to regain its footing as the market for Covid-19 vaccines has collapsed.
Moderna's $1 Billion Revenue Forecast Cut Sends Stock Plummeting Over 20%
Key Takeaways Moderna shares tumbled Monday after the company cut its 2025 revenue forecast by $1 billion.The company expects much of its revenue to be realized in the back half of the year from its Covid-19 and RSV vaccines.
Moderna cuts 2025 sales forecast by $1B on weak vaccine demand
Moderna cut its 2025 sales forecast by $1 billion today, hurt by a slow adoption of its respiratory syncytial virus (RSV) shot and weak demand for COVID-19 vaccines, sending its shares down more than 18% in premarket trading.
Moderna stock plunges 18% after company lowers 2025 sales forecast by $1 billion
Moderna now expects 2025 revenue to come in between $1.5 billion and $2.5 billion, most of which will come in the second half of the year.
Moderna Stock Crashes 21% After Covid Vaccine Maker Slashes 2024-25 Guidance
Moderna stock crashed Monday after the firm slashed its outlooks for 2024 and 2025, and announced an expanded cost-cutting initiative.
People’s Pharmacy: Could this medication help post-COVID-19 brain fog?
Scientists do not appear to have studied valacyclovir for post-COVID-19 brain fog. Another reader found valacyclovir helpful, ...
Arizona business owner sentenced to prison after using COVID-19 loans on home, travel
A 51-year-old business owner is going to prison after a conviction of fraud for misusing COVID-19 loans from the government.
Did Yale Scientists Find COVID-19 Spike Proteins in Vaccinated People? What We Know About Rumor
Speculation about the alleged findings of a study on long COVID and post-vaccination syndrome spread widely among vaccine ...
How to protect yourself from norovirus, COVID-19, flu and RSV during the winter surge
There’s no medication for norovirus. Instead, you’ll need to rehydrate as much as possible with water and other liquids. Seek ...
CNN on MSN13d
After a long lull, Covid-19 levels are surging in the US
After a relatively slow start to the respiratory virus season, Covid-19 levels in the United States began ramping up just ...
Hosted on MSN18h
Is HMPV the same as Covid-19? Debunking 9 HMPV myths
Human metapneumovirus (hMPV) cases are on the rise, with India reporting 17 cases in recent days. Health officials have urged ...
EurekAlert!1d
COVID-19 vaccine developed at University of São Paulo presents promising results in animal trials
Studies conducted in mice have shown that the COVID-19 vaccine being developed by researchers at the University of São Paulo’s Medical School (FM-USP) in Brazil is safe and efficacious. The vaccine ...
Covid-19: Over 7 Million Deaths Recorded In 5 Years
In 2023, the WHO estimated that the real death toll of the pandemic was at least 20 million Covid-19: over 7 million deaths ...
Why The U.S. Could Be Making The Same Mistakes With Bird Flu As It Did With COVID-19
The first severe human case of bird flu was recently reported in the U.S. Here are some ways the U.S. may be repeating the ...
Map: See hospital rates for COVID-19, the flu, and RSV in New York
Infections of respiratory illnesses are on the rise, according to statistics from the Centers for Disease and Prevention. A ...
Covid-19 matric overcomes pandemic era with seven distinctions
Crawford International's Ameerah Carrim-Ganey conquered adversity to achieve seven distinctions in her IEB matric exams.